This multidisciplinary conference on "Fibrous Protein Nanocomposites for Tailored Hybrid Biostructures and Devices" will address the state of the art in the design, synthesis and characterization of hybrid bio-nano- materials and devices for electronic and nanomedicine applications.
University of Minnesota engineering researchers are leading an international team that has made a major breakthrough in developing a catalyst used during chemical reactions in the production of gasoline, plastics, biofuels, pharmaceuticals, and other chemicals. The discovery could lead to major efficiencies and cost-savings in these multibillion-dollar industries.
In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.
From September 26-27, 2012 the Raman Spectroscopy community will again meet in Ulm, Germany for the 9th Symposium on "Confocal Raman Imaging". It will cover various aspects of modern Raman microscopy and will provide an introduction to Raman spectroscopy in general as well as operational principles and instrumentation relevant to the techniques.
Draper Laboratory is designing a microdevice that will provide a more biologically realistic growth environment for human kidney cells in the laboratory. The proof-of-concept "kidney-on-a-chip" could one day give scientists a more accurate platform for drug screening or disease modeling.
Researchers at Thailand's National Nanotechnology Center (NANOTEC) have build the first locally made prototype solar powered water purification unit "SOS water" which combined the use of antimicrobial nanocoating to ceramic filters.
Das Ferdinand-Braun-Institut, Leibniz-Institut für Höchstfrequenztechnik (FBH) arbeitet im EU-Verbundprojekt iSense am Prototyp eines tragbaren, integrierten Quantensensors, der auf ultrakalten Atomen basiert. Dieser könnte beispielsweise die Erdbeschleunigung messen - in hoher Genauigkeit und an jedem Ort der Erde.
The future of prostate cancer therapy may lie in a tiny, "sticky" silicon chip dubbed GEDI (Geometrically Enhanced Differential Immunocapture) that can identify and collect cancer cells from a patient's bloodstream.